Coronary stenting and use of abciximab.
Alvarez
J M
JM
D000077284:Abciximab; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D000925:Anticoagulants / Q000009:adverse effects*; D002986:Clinical Trials as Topic; D001026:Coronary Artery Bypass; D004630:Emergencies; D006801:Humans; D007140:Immunoglobulin Fab Fragments / Q000009:adverse effects*; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects*; D015607:Stents / Q000009:adverse effects*; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D000925:Anticoagulants; D007140:Immunoglobulin Fab Fragments; D010975:Platelet Aggregation Inhibitors; D000077284:Abciximab